← Leaderboards
Richard K Albert
University Of Washington
$5,286,027
Attributed
$5,286,027
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–16$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$5,286,027 · 9
By mechanism
U10$4,091,822 · 1
N01$1,105,323 · 2
M01$88,882 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Peter J Leary$6,420,826
- Engi Farouk Attia$1,255,711
- Coralynn Shayna Sack$1,281,828
- Anne M Manicone$7,772,368
- Kanchan A Chitaley$2,668,818
Others in their field
Top investigators on “Chronic Obstructive Airway Disease”
- James D Crapo · University Of Colorado Denver$90,851,150
- Edwin K Silverman · Brigham And Women'S Hospital$66,435,690
- Prescott G Woodruff · University Of California San Francisco$44,725,610
- Bryan O Buchholz · University Of Massachusetts Lowell$40,621,016
- David D. McManus · Univ Of Massachusetts Med Sch Worcester$40,621,016
- Jane Wilkinson · Broad Institute, Inc.$38,181,500
Research focus
Chronic Obstructive Airway DiseaseOxygenHypoxemiaMortality Vital StatisticsUnited States National Institutes Of HealthAcuteChronicCostResourcesResearch PersonnelGrantTreatment TrialInstitutionFundingComputer Retrieval Of Information On Scientific Projects DatabaseQuality Of LifeSourceMacrolide AntibioticsAnti-Inflammatory AgentsDouble-Blind MethodAnti-Bacterial AgentsPlacebosOxygen Therapy CarePlacebo Control
Grant awards (17)
Long-term Oxygen Treatment Trial$11,563
N01 · FY2016 · HL · contact PI
LONG-TERM OXYGEN TREATMENT TRIAL (LOTT) - REGIONAL CLINICAL CENTER$46,775
N01 · FY2015 · HL · contact PI
OPTION PERIOD II: 9/01/2013 - 12/31/2014, LOTT$97,816
N01 · FY2013 · HL · contact PI
Long-term Oxygen Treatment Trial$354,328
N01 · FY2012 · HL · contact PI
Long-term Oxygen Treatment Trial$370,290
N01 · FY2010 · HL · contact PI
CLINICAL TRIAL: EFFECT OF CHRONIC MACROLIDE ADMINISTRATION ON COPD EXACERBATIONS$6,407
M01 · FY2008 · RR · contact PI
EFFECT OF CHRONIC MACROLIDE ADMIN ON THE FREQNCY & SEVERTY OF COPD EXACERBATIONS$3,401
M01 · FY2008 · RR · contact PI
Novel Strategies Targeting Acute Exacerbation of COPD$982,969
U10 · FY2007 · HL · contact PI
EFFECT OF CHRONIC MACROLIDE ADMINISTRATION ON COPD EXACERBATIONS$41,404
M01 · FY2007 · RR · contact PI
EFFECT OF CHRONIC MACROLIDE ADMIN ON THE FREQNCY & SEVERTY OF COPD EXACERBATIONS$28,950
M01 · FY2007 · RR · contact PI
BENEFITS OF AMBULATORY OXYGEN IN HYPOXEMIC COPD PATIENTS$674
M01 · FY2007 · RR · contact PI
Novel Strategies Targeting Acute Exacerbation of COPD$798,959
U10 · FY2006 · HL · contact PI
BENEFITS OF AMBULATORY OXYGEN IN HYPOXEMIC COPD PATIENTS$8,046
M01 · FY2006 · RR · contact PI
Novel Strategies Targeting Acute Exacerbation of COPD$641,872
U10 · FY2005 · HL
Novel Strategies Targeting Acute Exacerbation of COPD$752,377
U10 · FY2004 · HL
Novel Strategies Targeting Acute Exacerbation of COPD$915,645
U10 · FY2003 · HL
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTER$224,551
N01 · FY2000 · HR